Fresenius Kabi
Ces Salaan, CMA, is an experienced financial professional with a strong background in business planning and analysis. Currently serving as the Manager of Business Planning and Analysis at Fresenius Kabi since August 2021, Ces previously held positions at Merck Group as Lead of Controlling Services, at Teleperformance as Manager of Financial Planning and Analysis, at Citibank as Manager of Finance and Risk Operations, at Tupperware Brands as Sr. Supervisor of Financial Planning and Analysis, and at BMW as Accountant in Financial Planning and Controlling. Educational qualifications include a degree from Adamson University and certification as a CMA from the Institute of Certified Management Accountants in Australia. Ces has expertise in variance analysis, budgeting, forecasting, cost reduction proposals, financial reporting, and process improvements.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
16 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.